Kymera Therapeutics, Inc.
KYMRCIK 0001815442 · last filing Jul 7, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
191,378 bought / 287,148 sold
net −95,770 sh · −$32.11M
- buys
- 3
- sells
- 29
- insiders active
- 4
Filing tape
Filed Tue, Jul 7, 2026
- −0 sh · $5.85M
Mainolfi Nello — Chief Executive Officer · Director
- Exercised50,000Common Stock@ $2.08→ 716,568 held
- Sold50,000Common Stock@ $119.00→ 666,568 held
- Exercised45,559Stock Option (Right to Buy)→ 90,000 held
- Exercised4,441Stock Option (Right to Buy)→ 14,284 held
Filed Thu, Jul 2, 2026
- −76,650 sh · $8.28M
Booth Bruce — Directoramended
- Sold5,549Common Stock@ $105.78→ 2,446,375 held
- Sold14,798Common Stock@ $106.63→ 2,431,577 held
- Sold19,419Common Stock@ $107.76→ 2,412,158 held
- Sold10,848Common Stock@ $108.28→ 2,401,310 held
- Sold7,968Common Stock@ $109.75→ 2,393,342 held
- Sold7,723Common Stock@ $110.67→ 2,385,619 held
- Sold934Common Stock@ $111.20→ 2,384,685 held
- Sold770Common Stock@ $105.78→ 471,497 held
- Sold2,133Common Stock@ $106.63→ 469,364 held
- Sold2,698Common Stock@ $107.76→ 466,666 held
- Sold1,498Common Stock@ $108.28→ 465,168 held
- Sold1,104Common Stock@ $109.75→ 464,064 held
- Sold1,078Common Stock@ $110.67→ 462,986 held
- Sold130Common Stock@ $111.20→ 462,856 held
- −15,731 sh · $8.54M
Jacobs Bruce N. — Chief Financial Officer
- Exercised61,378Common Stock@ $5.33→ 321,992 held
- Sold1,500Common Stock@ $110.54→ 320,492 held
- Sold1,700Common Stock@ $111.57→ 318,792 held
- Sold1,100Common Stock@ $112.79→ 317,692 held
- Sold4,110Common Stock@ $114.19→ 313,582 held
- Sold51,375Common Stock@ $114.77→ 262,207 held
- Sold7,971Common Stock@ $115.82→ 254,236 held
- Sold6,153Common Stock@ $116.99→ 248,083 held
- Sold3,200Common Stock@ $117.70→ 244,883 held
- Exercised61,378Stock Option (Right to Buy)→ 0 held
- −3,389 sh · $387.3K
Goodman Noah — Chief Business Officer
- Sold3,389Common Stock@ $114.29→ 47,179 held
- −0 sh · $9.06M
Mainolfi Nello — Chief Executive Officer · Director
- Exercised80,000Common Stock@ $2.08→ 746,568 held
- Sold1,883Common Stock@ $112.80→ 744,685 held
- Sold6,626Common Stock@ $113.98→ 738,059 held
- Sold24,105Common Stock@ $114.96→ 713,954 held
- Sold44,050Common Stock@ $115.69→ 669,904 held
- Sold3,336Common Stock@ $116.56→ 666,568 held
- Exercised80,000Stock Option (Right to Buy)→ 135,559 held
Insiders on this tape
- Mainolfi NelloChief Executive Officer · Director
- Booth BruceDirector
- Jacobs Bruce N.Chief Financial Officer
- Goodman NoahChief Business Officer
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.